Trial Profile
A Phase 1 Pilot Study of 99mTc-MIP-1404 Single Photon Emission Computed Tomography (SPECT)/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection (PLND)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Technetium tc 99m trofolastat (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Sponsors Molecular Insight Pharmaceuticals
- 24 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2014 New trial record